# A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

> **NCT00129818** · PHASE4 · COMPLETED · sponsor: **Novartis**

## Conditions studied

- Genital Herpes

## Interventions

- **DRUG:** Famciclovir

## Key facts

- **NCT ID:** NCT00129818
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129818, "A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00129818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*